Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Medecine Sciences : M/S
|
November 17, 2023
[GDF5: a therapeutic candidate for combating sarcopenia]
France Piétri-Rouxel, Sestina Falcone, Massiré Traoré
Scientific Reports
|
January 11, 2018
RFX1 and RFX3 Transcription Factors Interact with the D Sequence of Adeno-Associated Virus Inverted Terminal Repeat and Regulate AAV Transduction
Laura Julien, Julie Chassagne, Cécile Peccate, et al.
Lipids in Health and Disease
|
October 20, 2006
Is oxygen a key factor in the lipodystrophy phenotype?
Christel Gentil, Sébastien Le Jan, Josette Philippe, et al.
Mitochondrion
|
July 30, 2005
Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis
Caroline Petit, France Piétri-Rouxel, Annick Lesne, et al.
Molecular Therapy. Methods & Clinical Development
|
April 30, 2020
Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice
Anne Forand, Antoine Muchir, Nathalie Mougenot, et al.
Human Molecular Genetics
|
May 17, 2012
Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation
Christel Gentil, France Leturcq, Rabah Ben Yaou, et al.
The EMBO Journal
|
December 25, 2009
DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis
France Piétri-Rouxel, Christel Gentil, Stéphane Vassilopoulos, et al.
Scientific Reports
|
June 11, 2022
Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription
Amédée Mollard, Cécile Peccate, Anne Forand, et al.
Skeletal Muscle
|
April 29, 2018
miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
Marine Guilbaud, Christel Gentil, Cécile Peccate, et al.
Human Gene Therapy
|
June 10, 2016
Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy
Christel Gentil, Caroline Le Guiner, Sestina Falcone, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Medecine Sciences : M/S
|
November 17, 2023
[GDF5: a therapeutic candidate for combating sarcopenia]
France Piétri-Rouxel, Sestina Falcone, Massiré Traoré
Scientific Reports
|
January 11, 2018
RFX1 and RFX3 Transcription Factors Interact with the D Sequence of Adeno-Associated Virus Inverted Terminal Repeat and Regulate AAV Transduction
Laura Julien, Julie Chassagne, Cécile Peccate, et al.
Lipids in Health and Disease
|
October 20, 2006
Is oxygen a key factor in the lipodystrophy phenotype?
Christel Gentil, Sébastien Le Jan, Josette Philippe, et al.
Mitochondrion
|
July 30, 2005
Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis
Caroline Petit, France Piétri-Rouxel, Annick Lesne, et al.
Molecular Therapy. Methods & Clinical Development
|
April 30, 2020
Combined Treatment with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomer-PPMO and AAV-U7 Rescues the Severe DMD Phenotype in Mice
Anne Forand, Antoine Muchir, Nathalie Mougenot, et al.
Human Molecular Genetics
|
May 17, 2012
Variable phenotype of del45-55 Becker patients correlated with nNOSμ mislocalization and RYR1 hypernitrosylation
Christel Gentil, France Leturcq, Rabah Ben Yaou, et al.
The EMBO Journal
|
December 25, 2009
DHPR alpha1S subunit controls skeletal muscle mass and morphogenesis
France Piétri-Rouxel, Christel Gentil, Stéphane Vassilopoulos, et al.
Scientific Reports
|
June 11, 2022
Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription
Amédée Mollard, Cécile Peccate, Anne Forand, et al.
Skeletal Muscle
|
April 29, 2018
miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context
Marine Guilbaud, Christel Gentil, Cécile Peccate, et al.
Human Gene Therapy
|
June 10, 2016
Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy
Christel Gentil, Caroline Le Guiner, Sestina Falcone, et al.
Page
of 2